(Q46901919)
Statements
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment (English)
Kurt Højlund
Henning Beck-Nielsen
13 November 2007